2765936
2765936
ebooknice.com
ebooknice.com
ebooknice.com
(Ebook) Gulf War and Health : Vol. 7: Long-Term
Consequences of Traumati by Committee on Gulf War and
Health: Brain Injury in Veterans and Long-Term Health
Outcomes,      Board on Population Health and Public Health
https://ebooknice.com/product/gulf-war-and-health-vol-7-long-term-
Practice, Institute of Medicine ISBN 9780309124089,
consequences-of-traumati-5396414
0309124085
ebooknice.com
https://ebooknice.com/product/sat-ii-success-
math-1c-and-2c-2002-peterson-s-sat-ii-success-1722018
ebooknice.com
ebooknice.com
ebooknice.com
ebooknice.com
Gulf War and health 1st Edition Committee On Gulf War
And Health: Infectious Diseases Digital Instant Download
Author(s): Committee on Gulf War and Health: Infectious Diseases, Abigail E.
Mitchell, Laura B. Sivitz, Robert E. Black
ISBN(s): 9780309101066, 0309101069
Edition: 1
File Details: PDF, 1.70 MB
Year: 2006
Language: english
Abigail E. Mitchell, Laura B. Sivitz, Robert E. Black, Editors
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National
Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National
Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report
were chosen for their special competences and with regard for appropriate balance.
This study was supported by Contract V101(93)P-2155 between the National Academy of Sciences and the
Department of Veterans Affairs. Any opinions, findings, conclusions, or recommendations expressed in this
publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that
provided support for this project.
Additional copies of this report are available from the National Academies Press, 500 Fifth Street, NW, Lockbox
285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet,
http://www.nap.edu.
For more information about the Institute of Medicine, visit the IOM home page at www.iom.edu.
The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the
beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from
ancient Greece, now held by the Staatliche Museen in Berlin.
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars
engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their
use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has
a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone
is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter of the National Academy of
Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the
selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal
government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national
needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Wm. A. Wulf
is president of the National Academy of Engineering.
The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of
eminent members of appropriate professions in the examination of policy matters pertaining to the health of the
public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional
charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care,
research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine.
The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad
community of science and technology with the Academy’s purposes of furthering knowledge and advising the
federal government. Functioning in accordance with general policies determined by the Academy, the Council has
become the principal operating agency of both the National Academy of Sciences and the National Academy of
Engineering in providing services to the government, the public, and the scientific and engineering communities.
The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr.
Wm. A. Wulf are chair and vice chair, respectively, of the National Research Council.
www.national-academies.org
.
COMMITTEE ON GULF WAR AND HEALTH: INFECTIOUS DISEASES
ROBERT E. BLACK, MD, MPH, Edgar Berman Professor and Chair, Department of
     International Health, Johns Hopkins University, Bloomberg School of Public Health,
     Baltimore, MD
MARTIN J. BLASER, MD, Frederick H. King Professor of Internal Medicine, Chair of the
     Department of Medicine, and Professor of Microbiology, New York University School of
     Medicine, New York
RICHARD D. CLOVER, MD, Dean and Professor, School of Public Health and Information
     Sciences, University of Louisville, KY
MYRON S. COHEN, MD, J. Herbert Bate Distinguished Professor of Medicine and
     Microbiology, Immunology and Public Health, University of North Carolina School of
     Medicine, Chapel Hill
JERROLD J. ELLNER, MD, Professor and Chair of the New Jersey Medical School at the
     University of Medicine and Dentistry of New Jersey, Newark
JEANNE MARRAZZO, MD, MPH, Associate Professor, Department of Medicine, University
     of Washington School of Medicine, Seattle
MEGAN MURRAY, MD, ScD, MPH, Assistant Professor of Epidemiology, Harvard
     University, School of Public Health, Boston, MA
EDWARD C. OLDFIELD III, MD, Director, Division of Infectious Diseases, Eastern Virginia
     Medical School, Norfolk
RANDALL R. REVES, MD, MSc, Professor, Division of Infectious Diseases, University of
     Colorado Health Sciences Center, Denver
EDWARD T. RYAN, MD, Director, Tropical and Geographic Medicine Center, Massachusetts
     General Hospital, and Associate Professor of Medicine, Harvard Medical School, Boston,
     MA
STEN H. VERMUND, MD, PhD, Amos Christie Chair and Director, Vanderbilt University
     Institute for Global Health, and Professor of Pediatrics, Medicine, Preventive Medicine,
     and Obstetrics and Gynecology, Vanderbilt University School of Medicine, Nashville,
     TN
DAWN M. WESSON, PhD, Associate Professor, Tulane School of Public Health and Tropical
     Medicine, New Orleans, LA
                                             v
                                     STAFF
                                        vi
                                        REVIEWERS
        This report has been reviewed in draft form by persons chosen for their diverse
perspectives and technical expertise in accordance with procedures approved by the National
Research Council’s Report Review Committee. The purpose of this independent review is to
provide candid and critical comments that will assist the institution in making its published
report as sound as possible and to ensure that the report meets institutional standards of
objectivity, evidence, and responsiveness to the study charge. The review comments and draft
manuscript remain confidential to protect the integrity of the deliberative process. We wish to
thank the following for their review of this report:
        Although the reviewers listed above have provided many constructive comments and
suggestions, they were not asked to endorse the conclusions or recommendations nor did they
see the final draft of the report before its release. The review of this report was overseen by
George Rutherford, Institute of Global Health, University of California, San Francisco, and
Elaine L. Larson, School of Nursing, Columbia University. Appointed by the National Research
Council, they were responsible for making certain that an independent examination of this report
was carried out in accordance with institutional procedures and that all review comments were
carefully considered. Responsibility for the final content of this report rests entirely with the
authoring committee and the institution.
                                               vii
                                          PREFACE
        Infectious diseases have been a problem for military personnel throughout history. The
consequences in previous conflicts have ranged from frequent illnesses disrupting daily activities
and readiness to widespread deaths. Preventive measures, early diagnosis, and treatment greatly
limit the exposures and acute illnesses of troops today in comparison with those in armies of the
past, but infections and consequent acute illnesses still occur. In addition, long-term adverse
health outcomes of some pathogens are increasingly recognized.
        The deployment of about 700,000 US troops to the Persian Gulf region in the Gulf War
of 1991 potentially exposed them to pathogens that they had not encountered at home. After
returning from that short campaign, some veterans reported symptoms and expressed the concern
that they may have been exposed to biologic, chemical, or physical agents during their service in
the Persian Gulf. In response to those concerns, the US Department of Veterans Affairs (VA)
commissioned the Institute of Medicine (IOM) to review the scientific evidence on possible
long-term adverse health outcomes of exposure to specific biologic, chemical, and physical
agents and to draw conclusions on the strength of that evidence with regard to delayed and
chronic illnesses of the veterans.
        The authorizing legislation for the work of IOM included several infectious diseases
endemic in the Persian Gulf region. In the charge to our committee, VA asked that we not limit
consideration to those diseases but rather include all infectious exposures that had been
documented in troops and consider their possible long-term adverse health outcomes. It further
requested that the time and geographic dimensions of the committee’s work be widened to
include military personnel deployed as part of Operation Enduring Freedom (OEF) in
Afghanistan and Operation Iraqi Freedom (OIF) in the Persian Gulf region. OEF began in 2001,
and OIF in 2003; they continued as this report went to press. The number of military personnel
involved in the more recent conflicts now exceeds that in the 1991 Gulf War. Furthermore, they
have remained for much longer periods on the average than in the Gulf War, and many have
been deployed for more than one tour in this region. Thus, the potential for exposure to endemic
pathogens is greater in these troops than in those deployed to the Gulf War. Because the possible
exposures are relatively recent, there has been only a short time to observe long-term adverse
health outcomes. The committee needed to rely on observations from the Gulf War, information
on infectious diseases in OEF and OIF, and evidence in the scientific literature to allow
conclusions to be drawn on possible long-term adverse health outcomes. With further time to
observe the possible consequences of infectious exposures, the knowledge base will increase.
Given the continuing presence of troops in the areas and the variable nature of infectious
diseases, the exposures may change.
        Valuable contributions were made to this study by a number of people who shared their
expertise on infectious diseases. On behalf of the committee, I thank several of them—K. Craig
Hyams, MD, MPH, chief consultant, Occupational and Environmental Health Strategic
Healthcare Group, VA; Michael Kilpatrick, MD, deputy director, Deployment Health Support,
Department of Defense (DOD); and Alan Magill, MD, science director, Walter Reed Army
Institute of Research, for presenting information on infectious diseases that have been diagnosed
in military personnel during the Gulf War, OIF, and OEF and Richard Reithinger, PhD,
                                                ix
x                                                                                       PREFACE
infectious diseases consultant, for presenting information on infectious diseases that are endemic
in southwest and south-central Asia to the committee at its May 26, 2005 meeting. I also thank
William Winkenwerder, Jr., MD, MBA, assistant secretary for defense for health affairs, and his
staff at DOD’s Deployment Health Support for expeditiously providing information to the
committee on DOD health-related policies. Finally, the committee is grateful for the insight
provided by representatives of veteran service organizations, veterans, and others who spoke
with the committee or sent in written testimony.
         I am grateful for the great expertise the committee members brought to bear on this
subject. Furthermore, the report would not have been successfully completed without the diligent
and expert contributions of the IOM staff, led by Abigail Mitchell and including Laura Sivitz,
Deepali Patel, Michael Schneider, Peter James, Damika Webb, David Tollerud, and Renee
Wlodarczyk.
Summary ....................................................................................................................................1
    Methodology .........................................................................................................................1
     Identifying the Pathogens to Study.....................................................................................2
     Development of Conclusions..............................................................................................3
    Summary of Conclusions ......................................................................................................4
     Sufficient Evidence of a Causal Relationship ....................................................................4
     Sufficient Evidence of an Association................................................................................5
     Limited or Suggestive Evidence of an Association............................................................6
     Inadequate or Insufficient Evidence to Determine Whether an Association Exists...........6
     Limited or Suggestive Evidence of No Association...........................................................7
    Department of Defense Policies on Tuberculin Skin Testing and Predeployment and
       Postdeployment Serum Collection ...................................................................................7
1 Introduction...........................................................................................................................9
    Identifying the Infectious Diseases to Study.......................................................................13
    The Committee’s Approach to Its Charge ..........................................................................15
    Organization of the Report..................................................................................................16
    References ...........................................................................................................................16
2 Methodology .......................................................................................................................19
    Identifying the Infectious Diseases to Study.......................................................................19
      Geographic Boundaries ....................................................................................................19
      Infectious Diseases Endemic to Southwest and South-Central Asia
          That Have Long-Term Adverse Health Outcomes .....................................................20
      Direct Attribution to Military Service in Southwest and South-Central Asia ..................24
      Timing of Appearance of Long-Term Adverse Health Outcomes ...................................27
      The Infectious Diseases to Be Studied for Strength of Association
          with Long-Term Adverse Health Outcomes...............................................................27
      Comments on Diseases and Agents of Special Interest
         to Gulf War, OEF, and OIF Veterans ..........................................................................28
    Review and Evaluation of the Literature ............................................................................29
      Selection of the Literature ................................................................................................29
      Amassing the Literature....................................................................................................29
      Reviewing the Literature ..................................................................................................29
    Categories of Strength of Association.................................................................................30
      Origin and Evolution of the Categories ............................................................................30
      Sufficient Evidence of a Causal Relationship ..................................................................30
      Sufficient Evidence of an Association..............................................................................31
      Limited or Suggestive Evidence of an Association..........................................................31
      Inadequate or Insufficient Evidence to Determine Whether an Association Exists.........31
                                                                       xi
xii                                                                                                                                CONTENTS
4 Infectious Diseases Diagnosed in US Troops Who Served in the Persian Gulf War,
  Operation Enduring Freedom, or Operation Iraqi Freedom................................................61
      Diarrheal Disease ................................................................................................................62
        Enteric Infections in the Gulf War....................................................................................62
        Gastroenteritis in Operation Enduring Freedom and Operation Iraqi Freedom ...............69
      Respiratory Disease.............................................................................................................74
        Mild Acute Respiratory Disease in the Gulf War.............................................................74
        Severe Acute Respiratory Disease in the Gulf War..........................................................76
        Respiratory Disease in Operation Enduring Freedom and Operation Iraqi Freedom ......76
      Insect-Borne Diseases .........................................................................................................78
        Leishmaniasis ...................................................................................................................78
        Malaria..............................................................................................................................82
        West Nile Fever ................................................................................................................84
      Brucellosis...........................................................................................................................84
      Chicken Pox (Varicella)......................................................................................................85
      Meningococcal Disease.......................................................................................................85
      Nosocomial Infections ........................................................................................................85
        Gulf War ...........................................................................................................................85
        Operation Enduring Freedom and Operation Iraqi Freedom............................................86
      Q Fever................................................................................................................................88
        Q Fever Contracted During the Gulf War ........................................................................89
        Q Fever Contracted During Operation Enduring Freedom
           and Operation Iraqi Freedom .......................................................................................89
      Viral Hepatitis .....................................................................................................................90
      Tuberculosis ........................................................................................................................90
      Department of Defense Medical Databases ........................................................................91
      Department of Defense Policy Regarding Predeployment
         and Postdeployment Serum Collection ..........................................................................93
      References ...........................................................................................................................94
  Brucellosis.........................................................................................................................112
   Transmission and Endemicity of Brucellosis .................................................................113
   Acute Brucellosis............................................................................................................114
   Treatments for Brucellosis and Related Long-Term Toxicity........................................115
   Coinfection .....................................................................................................................115
   Long-Term Adverse Health Outcomes of Brucellosis ...................................................115
  Leishmaniasis....................................................................................................................118
   Transmission of Leishmaniasis.......................................................................................119
   Endemicity in Southwest and South-Central Asia..........................................................120
   Acute Leishmaniasis.......................................................................................................120
   Diagnosis of Leishmaniasis ............................................................................................121
   Treatments for Leishmaniasis and Related Long-Term Toxicity...................................121
   Coinfection by Leishmania Parasite and Human Immunodeficiency Virus ..................122
   Long-Term Adverse Health Outcomes of Leishmaniasis ..............................................122
  Malaria ..............................................................................................................................123
   Transmission of Malaria .................................................................................................124
   Endemicity in Southwest and South-Central Asia..........................................................124
   Acute Malaria .................................................................................................................125
   Treatments for Malaria and Related Long-Term Toxicity .............................................125
   Coinfection with Plasmodium Spp. and Human Immunodeficiency Virus ...................126
   Long-Term Adverse Health Outcomes of Infection with Plasmodium Spp...................126
  Q Fever (Infection by Coxiella burnetii) ..........................................................................129
   Transmission of Coxiella burnetii ..................................................................................129
   Endemicity in Southwest and South-Central Asia..........................................................130
   Acute Q Fever.................................................................................................................130
   Diagnosing Q Fever........................................................................................................131
   Coinfection with Coxiella burnetii and Human Immunodeficiency Virus ....................131
   Long-Term Adverse Health Outcomes of Q Fever ........................................................132
  Tuberculosis ......................................................................................................................135
   Transmission of Tuberculosis.........................................................................................135
   Endemicity in Southwest and South-Central Asia..........................................................137
   Risk of Progression from Latent Tuberculosis Infection to Active Tuberculosis ..........137
   Treatment for Latent Tuberculosis Infection to Prevent Active Tuberculosis ...............140
   Active Tuberculosis ........................................................................................................140
   Late Manifestations of Active Tuberculosis...................................................................142
   Potential Relationships Between Tuberculosis and Military Service.............................144
  West Nile Virus Infection .................................................................................................149
   Transmission of West Nile Virus Infection ....................................................................150
   Endemicity in Southwest and South-Central Asia..........................................................150
   Acute West Nile Fever....................................................................................................151
   Diagnosis of West Nile Fever.........................................................................................151
   Treatment of West Nile Virus Infection .........................................................................152
   Long-Term Adverse Health Outcomes of Infection with West Nile Virus....................152
   Recommendation ............................................................................................................155
  References .........................................................................................................................155
xiv                                                                                                                                CONTENTS
6 Diseases and Agents of Special Concern to Veterans of the Gulf War, Operation Iraqi
  Freedom, and Operation Enduring Freedom.....................................................................181
    Al Eskan Disease ..............................................................................................................181
      Description of Acute Illness ...........................................................................................182
      Long-Term Adverse Health Outcomes...........................................................................182
      Pathogenesis ...................................................................................................................182
      Treatment........................................................................................................................183
      Summary.........................................................................................................................183
    Idiopathic Acute Eosinophilic Pneumonia........................................................................183
      Description of Acute Illness ...........................................................................................183
      Long-Term Adverse Health Outcomes...........................................................................183
      Pathogenesis ...................................................................................................................184
      Treatment........................................................................................................................184
      Summary.........................................................................................................................184
    Wound and Nosocomial Infections (Including Infections with Acinetobacter Spp.) ......184
      Concerns Regarding Acinetobacter baumannii ..............................................................185
      Other Wound Infections .................................................................................................186
      Other Nosocomial Infections..........................................................................................187
      Regional Experiences in Non-Americans.......................................................................188
      Summary.........................................................................................................................190
    Mycoplasmas ....................................................................................................................190
      Mycoplasmas and “Gulf War Illness” ............................................................................191
      Summary.........................................................................................................................193
    Biologic-Warfare Agents ..................................................................................................193
    Summary ...........................................................................................................................194
    References .........................................................................................................................194
Appendix Biographical Sketches for Members of the Committee .......................................201
Index ......................................................................................................................................205
                                                SUMMARY
        Thousands of US veterans of the Persian Gulf War have reported an array of unexplained
illnesses since the war ended in 1991. Many veterans have believed that the illnesses were
associated with their military service in southwest Asia during the war. In response, the US
Congress legislated in 1998 that the Department of Veterans Affairs (VA) use a specific
procedure to determine the illnesses that warrant presumption of a connection to Gulf War
service (Public Law [PL] 105-277, Persian Gulf War Veterans Act). Moreover, VA must
financially compensate Gulf War veterans in whom the determined illnesses are diagnosed (PL
105-368, Veterans Programs Enhancement Act). To reach those determinations, the law states,
VA must obtain independent evaluations of the scientific evidence of associations between
illnesses and exposures to various chemical, physical, and biologic substances connected to
military service in southwest Asia during the war. The law instructs VA to obtain the scientific
evaluations from the National Academy of Sciences (NAS). NAS assigned the task of evaluating
the associations to the Institute of Medicine (IOM).
        This report is the fifth volume produced by IOM for VA in response to the congressional
mandate.1 A committee of nationally recognized experts in infectious diseases was appointed and
charged with evaluating the scientific and medical literature on long-term adverse human health
outcomes associated with selected infectious diseases pertinent to Gulf War veterans. The
conclusions herein characterize the long-term adverse health outcomes associated with infection
by the following pathogens: Brucella species (spp.), the cause of brucellosis; Campylobacter
spp., nontyphoidal Salmonella spp. and Shigella spp., which cause diarrheal disease; Coxiella
burnetii, the cause of Q fever; Leishmania spp., the cause of leishmaniasis; Mycobacterium
tuberculosis, which causes tuberculosis; Plasmodium spp., the cause of malaria; and West Nile
virus, the cause of West Nile fever. The committee identified those pathogens through the
process outlined below. The committee then developed conclusions by studying the relevant
published evidence, deliberating to reach consensus, and responding to a formal process of peer
review.2
METHODOLOGY
        IOM appointed the Committee on Gulf War and Health: Infectious Diseases in January
2005. The committee considered infections that US troops might have contracted in southwest
Asia during the Persian Gulf War. At VA’s request, the committee also examined infections that
might have afflicted US military personnel deployed to south-central and southwest Asia for
Operation Enduring Freedom (OEF)3 and Operation Iraqi Freedom (OIF).4 Thus, the
committee’s deliberations covered infectious diseases known to occur in Saudi Arabia, Kuwait,
Iraq, Afghanistan, and most countries along their borders (Yemen, Oman, United Arab Emirates,
1
  Earlier IOM reports in this series present conclusions about long-term adverse health outcomes associated with
exposure to depleted uranium, pyridostigmine bromide, sarin, vaccines, insecticides, solvents, propellants,
combustion products, and fuels.
2
  A detailed description of how IOM studies are conducted appears at www.iom.edu/?id=32248.
3
  OEF began on October 7, 2001, in Afghanistan.
4
  OIF began on March 19, 2003.
                                                         1
2                                                                                    GULF WAR AND HEALTH
Qatar, Bahrain, Jordan, Israel, Lebanon, Syria, Iran, Turkmenistan, Uzbekistan, Tajikistan,
Kyrgyzstan, and Pakistan).
        The committee first identified about 100 naturally occurring pathogens that could
potentially have infected US troops during their service in the Gulf War, OEF, or OIF. The
identified pathogens comprise viruses, bacteria, helminths, and protozoa that have been reported
in southwest and south-central Asia, have historically caused outbreaks of illness in military
populations, or have generated particular concern among US veterans of the Persian Gulf War.
As required by PL 105-277 and PL 105-368, the pathogens include Escherichia coli, Shigella
spp., Leishmania spp., and the Phlebovirus pathogens that cause sand fly fever.
• Significant interruption of normal physical and mental function outside the timeframe of acute
  infection.
• Persistent organ dysfunction or damage.
• Reproductive effects in military personnel, including birth defects in their offspring.
        Many of the diseases have never been reported in US military personnel in close temporal
relationship to deployment to southwest or south-central Asia for the Gulf War, OEF, or OIF.
Even so, the committee could not rule out the possibility that one or more people contracted an
unreported disease during deployment. Consequently, the committee created a tabular summary
of such diseases’ acute and long-term characteristics.
5
 In this context, secondary transmission means the spread of a pathogen directly from a primary human host to one
or more other humans.
SUMMARY                                                                                                    3
        The committee further defined its infections of focus according to the likelihood that the
primary infection would be subacute or the infected person would be asymptomatic for days to
years, and the adverse health outcome would begin months to years after infection. In such cases,
diagnosis of the long-term adverse health outcome during military service in Asia would be
unlikely, and such infections were candidates for in-depth review and conclusions. In contrast,
military medical personnel would probably diagnose adverse health outcomes that are manifest
during the acute illness or shortly after a person’s deployment.
        Finally, the committee examined the likelihood that the candidate infections would have
occurred specifically during military deployment to southwest and south-central Asia during the
three operations in question. The risk of contracting the disease in the theater of operations must
have been equal to or greater than the risk of contracting it in the United States. Moreover, given
the natural history of the disease or infection, it must have been diagnosed in US troops in
appropriate temporal relationship to deployment.
        By applying those criteria to the dozens of infectious diseases recognized initially, the
committee identified the group that required in-depth evaluation and conclusions: brucellosis,
Campylobacter infection, leishmaniasis, malaria, Q fever, salmonellosis, and shigellosis. Two
other diseases did not meet all the criteria but still merited in-depth evaluation: tuberculosis and
West Nile virus infection.
        Tuberculosis (TB) could cause long-term adverse health outcomes in US troops and
veterans deployed to southwest and south-central Asia, where TB is highly endemic. TB has a
long history of activation and transmission in military settings. Moreover, about 2.5% of military
personnel deployed to OEF and OIF and given predeployment and postdeployment skin tests for
TB converted from negative to positive; that is, these troops acquired new TB infections during
deployment.6 Therefore, although the committee found no published reports of active TB cases
among the troops in question, conclusions about the long-term adverse health outcomes of TB
infection are quite pertinent.
        Unlike TB, West Nile virus (WNV) has been reported in troops deployed to southwest
and south-central Asia, where the virus is endemic. The long-term adverse health outcomes
associated with WNV infection are usually manifest during the acute illness—a characteristic
that disqualified other diseases from comprehensive evaluation in this report. Nevertheless,
dramatic changes in the epidemiology of WNV since the mid-1990s led the committee to make
an exception for WNV and to review it in depth.
        In addition, a small set of biologic agents, infections, and diseases that failed to meet the
committee’s inclusion criteria nevertheless raised serious questions that merited discussion: Al
Eskan disease, biowarfare agents, idiopathic acute eosinophilic pneumonia, mycoplasmal
infection, and wound infection (including wound infection caused by Acinetobacter baumanii,
the most notable pathogenic colonizer of wounds during OEF and OIF).
Development of Conclusions
6
 Kilpatrick ME. 2005. Presentation to IOM Committee on Gulf War and Health: Infectious Diseases. Washington,
DC.
4                                                                         GULF WAR AND HEALTH
references. On closer examination, some 1,200 references appeared to provide the requisite types
and quality of scientific evidence for this study.
SUMMARY OF CONCLUSIONS
• Brucellosis and
       o Arthritis and spondylitis; arthritis usually is manifest within 12 months of the acute
           illness, and spondylitis might be manifest later.
       o Hepatic abnormalities, including granulomatous hepatitis.
       o Chronic meningitis and meningoencephalitis.
       o Uveitis.
       o Orchioepididymitis and infections of the genitourinary system.
       o Cardiovascular, nervous, and respiratory system infections.
• Campylobacter jejuni infection and Guillain-Barré syndrome (GBS) if GBS is manifest within
  2 months of the infection.
• Campylobacter infection and reactive arthritis (ReA) if ReA is manifest within 3 months of
  the infection; most cases of ReA are manifest within 1 month of the infection.
• Coxiella burnetii infection (Q fever) and
       o Endocarditis years after primary infection.
       o Vascular infection years after primary infection.
       o Chronic hepatitis years after primary infection.
• Plasmodium malariae infection and manifestation of immune-complex glomerulonephritis
  years to decades later.
• Plasmodium falciparum infection and recrudescence weeks to months after the primary
  infection, but only in the case of inadequate therapy.
• Nontyphoid Salmonella infection and ReA if ReA is manifest within 3 months of the
  infection.
• Shigella infection and
       o Hemolytic-uremic syndrome (HUS) if HUS is manifest within 1 month of the
           infection; most cases of HUS are manifest within 10 days of the infection.
       o ReA if ReA is manifest within 3 months of the infection; most cases of ReA are
           manifest within 1 month of the infection.
• Active TB and long-term adverse health outcomes due to irreversible tissue damage from
  severe forms of pulmonary and extrapulmonary TB.
• Visceral leishmaniasis (kala-azar) and
       o Delayed presentation of the acute clinical syndrome.
       o Reactivation of visceral leishmaniasis in the context of future immunosuppression.
       o Post-kala-azar dermal leishmaniasis (PKDL) if PKDL occurs generally within 2 years
           of the initial infection.
6                                                                         GULF WAR AND HEALTH
• West Nile virus infection and variable physical, functional, or cognitive disability, which may
  persist for months or years or be permanent.
• Brucellosis and
       o Myelitis-radiculoneuritis, demyelinating meningovascular syndromes, deafness,
          sensorineural hearing loss, and GBS.
       o Papilledema, optic neuritis, episcleritis, nummular keratitis, and multifocal
          choroiditis.
       o Fatigue, inattention, amnesia, and depression.
• Campylobacter jejuni infection and development of uveitis if uveitis is manifest within 1
  month of infection.
• Coxiella burnetii infection and post-Q-fever chronic fatigue syndrome years after the primary
  infection.
• Plasmodium falciparum infection and neurologic disease, neuropsychiatric disease, or both
  months to years after the acute infection.
• Plasmodium vivax and Plasmodium falciparum infections and demyelinating polyneuropathy
  and GBS.
         Each branch of the US military has polices regarding tuberculin skin testing and
treatment of latent TB infection (LTBI). The most effective way to mitigate TB transmission and
activation is to identify and treat for LTBI. In addition, the only way to determine whether
military personnel and reservists have become infected with M. tuberculosis during their service
is to test all personnel for TB shortly before and after deployment. Such testing would make it
possible to trace cases of active TB to periods of military service if that is when infection
occurred.
         Department of Defense (DOD) policy specifies that predeployment serum specimens for
medical examinations will routinely be collected within 1 year of deployment and that
postdeployment serum specimens for medical examinations will be collected no later than 30
days after arrival at the demobilization site, home station, or in-patient medical treatment facility.
The committee agrees with DOD’s overall policy regarding collection and use of serum
specimens. However, for banked serum specimens to be most useful for determining whether
infectious exposures occurred during deployment, the predeployment specimens need to be
collected before travel. Current policy allows for collection of predeployment serum specimens
up to 1 year after deployment. If the collection of serum is not done until after deployment, it
would be difficult to ascertain whether any signs of infection found in the “predeployment”
specimen are due to exposure during the current deployment or before it.
                                               1
INTRODUCTION
        Five days after the Iraqi invasion of Kuwait on August 2, 1990, the United States
deployed troops to Operation Desert Shield (ODSh). The United States attacked Iraqi armed
forces by air on January 16, 1991, and this marked the beginning of Operation Desert Storm
(ODSt). The ground war began on February 24, 1991, and ended 4 days later. The official cease-
fire took effect on April 11, 1991, and the last troops to participate in the ground war arrived
back in the United States on June 13, 1991. In this report, ODSh and ODSt are also referred to
collectively as the Gulf War.
        About 697,000 US troops were deployed to the Persian Gulf during ODSh and ODSt.
Figure 1.1 depicts the size of the US military presence in the Persian Gulf from August 1990
through June 1991. The war was considered to be a successful military operation, and there were
few injuries and deaths.
        Shortly after returning to the United States, a number of veterans started reporting a
variety of symptoms—fatigue, headache, muscle and joint pain, sleep disturbances, and
cognitive difficulties (Persian Gulf Veterans Coordinating Board 1995). The veterans were
concerned that they might have been exposed to chemical, biologic, or physical agents during
their deployment to the Persian Gulf and that those exposures might be responsible for their
unexplained illnesses.
                                               9
                                                                                                                                                         10
500
400
300
200
100
           0
                               Operation Desert Shield (ODSh)                         Period of Combat
         August    September     October   November December      January     February      March        April          May   June        July
          1990                                                     1991
         8/7/90: First US troops arrive in                         1/16/91:                              4/11/91:             6/13/91: Last US troops
         Arabian Peninsula for Operation Desert                    Operation Desert                      Official             to participate in ground
         Shield                                                    Storm (ODSt)                          cease-fire           war arrive back in US
                                                                   begins                                takes effect
FIGURE 1.1 Operation Desert Shield and Operation Desert Storm: key dates and size of US military presence in theater.
SOURCE: DOD 2006; IOM 2000; PAC 1996.
INTRODUCTION                                                                                     11
        In response to the concerns of the Gulf War veterans about their unexplained illnesses,
the US Department of Veterans Affairs (VA) asked the Institute of Medicine (IOM) to conduct a
study to evaluate the scientific literature on chemical, biologic, and physical agents to which
military personnel in the gulf were potentially exposed and possible long-term adverse health
outcomes. In addition, Congress passed two laws in 1998—the Persian Gulf War Veterans Act
(PL 105-277) and the Veterans Programs Enhancement Act (PL 105-368)—that called for the
review of the scientific literature on specified agents with regard to long-term adverse health
outcomes. That legislation directs IOM to study a number of diverse chemical, biologic, and
physical agents (listed in Box 1.1). IOM divided the task into several reviews. It has completed
four reports: Gulf War and Health, Volume 1: Depleted Uranium, Pyridostigmine Bromide,
Sarin, Vaccines (IOM 2000); Gulf War and Health, Volume 2: Insecticides and Solvents (IOM
2003); Gulf War and Health Volume 3: Fuels, Combustion Products, and Propellants (IOM
2005); and Gulf War and Health, Volume 4: Health Effects of Serving in the Gulf War (IOM
2006). The present report is the fifth volume in the series. An additional, related report has also
been published: Gulf War and Health: Updated Literature Review of Sarin (IOM 2004).
        Since VA asked IOM to conduct the above-mentioned study and PL 105-277 and PL
105-368 were enacted, the United States has again entered into military conflicts in southwest
and south-central Asia—Operation Enduring Freedom (OEF) and Operation Iraqi Freedom
(OIF). Therefore, VA has asked IOM to make this report relevant to the military personnel
serving in OEF and OIF in addition to those who served in the 1991 Gulf War.
12                                                                               GULF WAR AND HEALTH
        In accordance with PL 105-277 and PL 105-368, IOM appointed the Committee on Gulf
War and Health: Infectious Diseases and tasked it to review, evaluate, and summarize the peer-
reviewed scientific and medical literature on long-term adverse health outcomes associated with
selected infectious diseases pertinent to service in the Gulf War. The infectious diseases can
include, but are not limited to, pathogenic Escherichia coli infection, shigellosis, leishmaniasis,
and sand fly fever.
        VA is also concerned about potential long-term adverse health outcomes of infectious
diseases in veterans of OEF and OIF. As of October 2005, about 1.2 million US troops have been
deployed to OEF or OIF (see Figure 1.2). VA asked IOM to evaluate infectious diseases
pertinent to service in OEF and OIF.
        It should be noted that the charge to IOM was not to determine whether a unique Gulf
War syndrome or Gulf War illness exists or to make judgments about whether individual
veterans were exposed to specific pathogens. Nor was the charge to focus on broader issues, such
as the potential costs of compensation for veterans or policy regarding compensation; such
decisions are the responsibility of the secretary of veterans affairs.
                                                                                                                                              14
450
400
350
300
250
200
150
100
50
         September   January    May       Sept     January     May        Sept     January    May     September   January   May   September
           2001       2002                          2003                            2004                           2005
          10/7/01                                       3/19/03
          Operation Enduring                            Operation Iraqi
          Freedom begins                                Freedom begins
FIGURE 1.2 Operation Enduring Freedom and Operation Iraqi Freedom: key dates and size of US military presence in theater.
SOURCE: Personal Communication, Michelle Rudolph, Branch Chief, Defense Manpower Data Center, December 15, 2005.
INTRODUCTION                                                                                    15
        A brief overview of how the committee approached its charge is presented here. A more
comprehensive explanation is provided in Chapter 2.
        The committee identified numerous infectious diseases to which Gulf War, OIF, and OEF
military personnel might have been exposed during their deployment. Dozens of infectious
diseases are endemic to southwest and south-central Asia, which includes Iraq, Kuwait, and
Afghanistan. The committee then determined which of the endemic infectious diseases are
known to have long-term adverse health outcomes. To determine which infectious diseases to
review in depth, the committee took several factors into account, including which ones were
diagnosed in military personnel who served in the Gulf War, OEF, or OIF and in veterans after
they returned home, as well as the prevalence of the infectious diseases in southwest and south-
central Asia compared with their prevalence in the United States.
        Overall, the incidence of infectious diseases among Gulf War military personnel was low
(Hyams et al. 1995). Acute diarrheal and acute respiratory diseases were the major causes of
morbidity from infectious diseases (Hyams et al. 1995; Hyams et al. 2001). The outbreaks of
diarrhea were due primarily to enterotoxigenic Escherichia coli and Shigella sonnei. Some 12
cases of viscerotropic leishmaniasis and 20 cases of cutaneous leishmaniasis were diagnosed in
Gulf War military personnel (Hyams et al. 1995; Hyams et al. 2001). Other reported infectious
diseases included Q fever (three cases), West Nile fever (one case), and malaria (seven cases)
(Hyams et al. 1995; Hyams et al. 2001).
        Infectious diseases reported in troops who served in OEF and OIF as of December 2005
are visceral and cutaneous leishmaniasis, malaria, diarrheal disease, respiratory disease,
tuberculosis infection (but not active tuberculosis), Q fever, brucellosis, and Acinetobacter
baumannii infection (Kilpatrick 2005). Chapter 4 reviews the literature on infectious diseases
that have been diagnosed in military personnel during or shortly after returning from the Gulf
War, OIF, or OEF.
        The committee identified for comprehensive evaluation nine infectious diseases known to
have long-term adverse health outcomes that were diagnosed in military personnel who served in
the Gulf War, OEF, or OIF. Some information is presented on a number of other infectious
diseases as well because they are endemic to southwest and south-central Asia, although there
have been no reported cases in military personnel through December 2005. It is possible that
military personnel have become infected but that no diagnosis was made either because no acute
symptoms were present or because the symptoms were mild and the soldier who had them did
not seek medical care. We also present information on diseases and agents of special concern to
veterans of the Gulf War, OEF, and OIF (Al Eskan disease, acute eosinophilic pneumonia,
Acinetobacter baumannii infection, mycoplasmas, and biological warfare agents).
        After determining which infectious diseases it would evaluate, the committee had to
identify the relevant literature for review. The committee relied primarily on peer-reviewed
published literature in developing its conclusions. It also consulted other material, such as
surveillance reports, technical reports, and textbooks, and it obtained additional information from
experts in infectious diseases of southwest and south-central Asia, from Deployment Health
Support at the Department of Defense (DOD), from Walter Reed Army Institute of Research,
from the VA Occupational and Environmental Health Strategic Healthcare Group, and from
veteran service organizations and Gulf War veterans. The committee focused on medical and
16                                                                        GULF WAR AND HEALTH
scientific data on long-term adverse health outcomes related to the infectious diseases it selected
for study.
        The final step in the committee’s evaluation process was to weigh the evidence on the
infectious diseases and their long-term adverse health outcomes and to develop conclusions
about the strength of the evidence. The conclusions are assigned to categories of association,
which range from sufficient evidence of a causal relationship to insufficient or inadequate
evidence of an association.
        This report includes discussion of acute diseases with potential long-term adverse health
outcomes caused by known pathogens. The committee acknowledges that there might be
clinically important pathogens that cannot be detected with available cultivation techniques
(Relman 2002). Because the extent to which such pathogens might contribute to acute illnesses
in military personnel is unknown, it is not possible to define a relationship between them and an
acute illness or long-term adverse health outcome.
         Chapter 2 lays out the committee’s process for selecting the infectious diseases to study
and reviewing and evaluating the evidence on them. Chapter 3 presents, in tabular format, the
endemic infectious diseases of southwest and south-central Asia that are known to have long-
term adverse health outcomes. Chapter 4 summarizes the body of literature on infectious diseases
that have been diagnosed in military personnel serving in the Gulf War, OIF, and OEF. The
committee’s comprehensive evaluations of selected infectious diseases are presented in Chapter
5, which also contains the committee’s conclusions. The final chapter, Chapter 6, presents
information about diseases and agents of special concern to veterans of the Gulf War, OIF, and
OEF that have an infectious component or have been implicated as a cause of “Gulf War
illness”.
REFERENCES
IOM. 2005. Gulf War and Health, Volume 3: Fuels, Combustion Products, and Propellants.
   Washington, DC: The National Academies Press.
IOM. 2006. Gulf War and Health, Volume 4: Health Effects of Serving in the Gulf War.
   Washington, DC: The National Academies Press.
Kilpatrick ME. 2005. Presentation to IOM Committee on Gulf War and Health: Infectious
   Diseases. Washington, DC.
 PAC (Presidential Advisory Committee). 1996. Presidential Advisory Committee on Gulf War
   Veterans’ Illnesses: Final Report. Washington, DC: US Government Printing Office.
Persian Gulf Veterans Coordinating Board. 1995. Unexplained illnesses among Desert Storm
   veterans. A search for causes, treatment, and cooperation. Persian Gulf Veterans
   Coordinating Board. Archives of Internal Medicine 155(3):262-268.
Relman DA. 2002. New technologies, human-microbe interactions, and the search for previously
   unrecognized pathogens. Journal of Infectious Diseases 186(2 Suppl):S254-S258.
                                                2
METHODOLOGY
       This chapter articulates the committee’s approach to its task. Of the dozens of pathogens
known to exist in southwest and south-central Asia, the committee identified the ones that are
known to cause long-term adverse health outcomes and infected at least one US veteran who
served in southwest or south-central Asia in the period 1991-December 2005. The committee
then oversaw a formal, comprehensive literature review that identified about 1,200 peer-
reviewed studies about the late complications and latent and chronic infections that might be
associated with primary infection by each of the pathogens. Those studies constituted the
evidence from which the committee drew conclusions about the relationship between each
primary infection and specific long-term adverse health outcomes in humans. Finally, the
committee ranked the strength of the relationships through the five-category system presented at
the end of this chapter.
Geographic Boundaries
         As required by law, the committee considered infectious diseases that might have
afflicted US troops who served in the 1991 Gulf War (PL 105-277 and PL 105-368).
Additionally, in response to a request by the Department of Veterans’ Affairs, the committee
considered infectious diseases that might have afflicted US troops during Operation Enduring
Freedom (OEF) or Operation Iraqi Freedom (OIF). Thus, the committee’s preliminary
deliberations covered infectious diseases known to occur specifically in Iraq, Kuwait, and
Afghanistan and in the geographic region that includes the Arabian Peninsula, Syria, Lebanon,
Israel, Iran, Qatar, Pakistan, Tajikistan, Kyrgyzstan, Uzbekistan, and Turkmenistan (Figure 2.1).
The term southwest and south-central Asia refers to that region throughout this report.
                                               19
20                                                                                     GULF WAR AND HEALTH
                                                            Uzbekistan
                                                                                      Kyrgyzstan
                                                   Turkmenistan
                                                                              Tajikistan
 Lebanon      Syria
                       Iraq                                     Afghanistan
  Israel                                       Iran
           Jordan
Kuwait Pakistan
                                          Qatar
                                  Bahrain Qatar
                      Saudi                                 United
                      Arabia                                 Arab
                                                      Oman Emirates
Yemen
FIGURE 2.1 Southwest and South-Central Asia. The committee’s preliminary deliberations covered infectious
diseases known to occur specifically in Iraq, Kuwait, and Afghanistan and in the geographic region that includes the
Arabian Peninsula, Syria, Iran, Qatar, Pakistan, Tajikistan, Kyrgyzstan, Uzbekistan, and Turkmenistan.
SOURCE: The National Academies Press.
 Infectious Diseases Endemic to Southwest and South-Central Asia That Have Long-Term
                                Adverse Health Outcomes
        The committee approached its task by first identifying infectious diseases that could have
affected US troops deployed to southwest and south-central Asia. The committee members drew
upon their collective knowledge of infectious diseases, which stems from both professional
experience (Appendix A) and information gathered specifically for this study. The committee
acquired information from numerous sources about illnesses diagnosed in troops deployed to
southwest and south-central Asia, infectious diseases known to occur in that region, and
conditions of special interest to veterans. The information came from peer-reviewed journal
articles, surveillance and technical reports, presentations by physicians and scientists, and
veterans and representatives of veterans’ groups.
METHODOLOGY                                                                                              21
TABLE 2.1 Diseases and Etiologic Agents Considered by the Committee for Evaluation
Disease                                             Etiologic Agent
Bacterial diseases
   Acinetobacter infection                          Acinetobacter baumanii and other Acinetobacter species
   Actinomycosis                                    Actinomyces spp.
   Anthrax                                          Bacillus anthracis
   Bartonellosis                                    Bartonella spp.
        Cat-scratch disease                             B. henselae
        Trench fever                                    B. quintana
   Botulism                                         Clostridium botulinum
   Brucellosis                                      Brucella spp.
   Campylobacteriosis                               Campylobacter spp.
   Capnocytophaga infection                         Capnocytophaga spp.
   Chlamydia
        Genital infections                          Chlamydia trachomatis
        Pneumonia                                   Chlamydia pneumoniae
   Cholera (including vibrio infections)            Vibrio spp.
   Diphtheria                                       Corynebacterium diphtheriae
   E. coli gastroenteritis                          Escherichia coli
                                                        Enterotoxigenic E. coli
                                                        Shiga toxin-producing E. coli
                                                        Enteroaggregative E. coli
                                                        Enteroinvasive E. coli
                                                        Enterohemorrhagic E. coli
                                                        Enteropathogenic E. coli
   Ehrlichioses                                     Ehrlichia spp.
   Enteric fever
       Paratyphoid fever                            Salmonella enterica serovar Paratyphi A,B,C
       Typhoid fever                                Salmonella enterica serovar Typhi
   Enterococcal infection (vancomycin-resistant)    Enterococcus spp.
   Gas gangrene                                     Clostridium perfringens
   Hemophilus meningitis                            Haemophilus influenzae
   Helicobacter infection                           Helicobacter pylori
   Klebsiella infection                             Klebsiella spp.
   Legionnaire’s disease                            Legionella spp.
   Leptospirosis                                    Leptospira spp.
   Listeriosis                                      Listeria monocytogenes
   Lyme disease                                     Borrelia burgdorferi
   Melioidosis                                      Burkholderia pseudomallei
   Meningococcal infection                          Neisseria meningitidis
   Moraxella infection                              Moraxella catarrhalis
22                                                                                  GULF WAR AND HEALTH
       Leishmaniasis
       Sand fly fever
       Pathogenic Escherichia coli infection
       Shigellosis
• Substantial interruption of normal physical and mental functioning occurring outside the
  timeframe of acute infection.
• Organ dysfunction or damage with a persistent effect.
• Reproductive effects in military personnel, including birth defects in offspring of military
  personnel.
A long-term adverse health outcome may be reversible. The committee also considered the
potential for secondary transmission of the pathogen.
        The application of these criteria to the infectious diseases listed in Table 2.1 generated
the infectious diseases contained in Box 2.2: infectious diseases that are endemic to southwest
and south-central Asia and have long-term adverse health outcomes.
       The committee examined the likelihood that the candidate infections would have
occurred specifically during military deployment to southwest and south-central Asia during the
METHODOLOGY                                                                                                   25
three operations in question. The risk of contracting a disease in the theater of operations must
have been equal to or greater than the risk of contracting it in the United States. Moreover, given
the natural history of the disease or infection, it must have been diagnosed in US troops in
appropriate temporal relationship to deployment.
        Chapter 4 comprises a review of infectious diseases that have been reported in US troops
in close temporal relationship to the operations under study. On the basis of that review, the
committee determined that many of the diseases in Box 2.2 have never been reported in US
military personnel in close temporal relationship to deployment to southwest or south-central
Asia during the Gulf War, OEF, or OIF. Nevertheless, it is impossible to prove that US troops
did not contract any of the unreported diseases during deployment. Thus, the committee
summarizes the acute and long-term characteristics of these unreported diseases in tabular form
in Chapter 3 and excludes them from further analysis.
    BOX 2.2 Infectious Diseases That Are Endemic in Southwest and South-Central Asia and Have Long-Term
                                           Adverse Health Outcomes
                                           Type of Etiologic Agent
Bacterium                           Virus                      Protozoan               Helminth
More prevalent in southwest or      More prevalent in          More prevalent in       More prevalent in
south-central Asia than in the      southwest or south-        southwest or south-     southwest or south-
United States                       central Asia than in the central Asia than in      central Asia than in
Anaplasmosis                        United States              the United States       the United States
Anthrax                             Crimean-Congo              Amebiasis               Ascariasis
Boutonneuse fever                     hemorrhagic fever        Cryptosporidiosis       Cysticercosis
Brucellosis                         Dengue fever               Cyclosporiasis          Echinococcosis
Campylobacter infection             Dengue hemorrhagic fever Giardiasis                Enterobiasis
Chancroid                           Dengue shock syndrome      Isosporiasis            Filariasis
Cholera                             Hepatitis A                Leishmaniasis           Hookworm disease
E. coli gastroenteritis             Hepatitis B                Malaria                 Onchocerciasis
Ehrlichiosis                        Hepatitis C                Microsporidiosis        Schistosomiasis
Enteric fever                       Rift Valley fever          Toxoplasmosis           Strongyloidiasis
Helicobacter infection              Sand fly fever
Leptospirosis                       Sindbis
Lymphogranuloma venereum
Melioidosis                         Potentially more
Plague                              prevalent among troops
Q fever                             in war theater than
Rat bite fever                      among US adult
Relapsing fever                     population
Salmonellosis (nontyphoid)          Adenovirus infection
Shigellosis                         Avian influenza
Syphilis                            Hantaviral hemorrhagic
Tuberculosis                          fever with renal
Typhus group (louse-borne and         syndrome
  murine)                           Hantavirus pulmonary
Yaws                                  syndrome
Yersinia enterocolitica infection   Influenza
                                    Viral enteritis
Potentially more prevalent among West Nile fever
troops in war theater than among
US adult population
Gonorrhea
Trichomoniasis
Exploring the Variety of Random
Documents with Different Content
home to a musical journal in Berlin that music 'lies still in the cradle
here and nourishes herself on sugar-teats.'
Dr. Lowell Mason was the chief assistant at an event which marks an
epoch in American musical education, namely, the birth of the
normal musical institute from the so-called musical convention. This
occurred in 1856 at North Reading, Mass., where an annual musical
convention of the usual sort was converted into a school of a
fortnight's duration for instructing its members, particularly teachers,
in both musical theory and practice. The example was followed all
over the country to the great benefit of musical pedagogy.
Associated with Dr. Mason in this work of popularizing music was
George F. Root, who journeyed over the country conducting
conventions, lecturing, etc.[58]
                                   V
During the second half of the nineteenth century the teaching of
music passed in large measure from the hands of single,
independent teachers into the direction of music masters associated
in institutions for class instruction, which are generally known as
conservatories, although this term in its European signification of a
large, completely equipped and nationally endowed school of music
is misleading. Indeed, the pretense seems to have been deliberate.
Dr. Frank Damrosch, in an address on 'The American Conservatory,'
before the Music Teachers' National Association at Oberlin, Ohio, in
1906, said:
In the first place, the institution had a natural origin: it was formed
to teach psalmody to a religious community and, in growing beyond
this limited field by adding one musical feature after another as the
developing taste of the people demanded, it typifies the history of
music in the nation. Secondly, the conservatory has a proper
environment. It was planted in a soil already enriched by culture,
Oberlin being the seat of a college distinguished for progressive
ideas and high ideals, the reaction of which upon musical work is
always inspiring—indeed, is essential to the highest achievement.
Thirdly, the Oberlin Conservatory has a proper organization. It is a
social democracy and thereby calculated to produce that free and
fraternal spirit which is the soul of art. Young men and women meet
on equal terms and there are no distinctions among them based on
wealth or nationality or even race, Oberlin having been the first
college to include negroes among its students. Lastly, the
conservatory has a sound program and is living up to this as well as
could be expected in view of the pressure exerted on all 'schools of
the people,' to supply immediate demands. It believes in
constructive work, in learning by doing. Thus it regards a practical
knowledge of the science of musical composition as necessary to an
intelligent appreciation of musical masterpieces, and to this end has
established a course in theory and composition which requires four
years of hard study and assiduous practice. The class system of
instruction is the one adopted as the chief method, it being
supplemented by private instruction.
                                  VI
Henry Dike Sleeper, professor of music in Smith College, a women's
college of the first rank, has made an interesting analysis of the
character of musical instruction given in the leading universities and
colleges where the subject is taught. He says that there are four
ideals of study:
1. Musical composition: Great emphasis is laid on this at the
University of Pennsylvania, and it is a predominant, though lesser
element in the schemes of Harvard and Yale.
In the same year that music was made a part of the curriculum of
Harvard (1875), classes in music were inaugurated at the University
of Pennsylvania under Professor Hugh A. Clarke. As has already been
stated, the attention paid to composition is the distinguishing feature
of the course.
Since our Western State universities form each the summit of public
education in its state, such institutions as Michigan pay much
attention to training teachers of music in the public schools. The
University of Wisconsin goes much further than this. In connection
with its admirable University School of Music, which is one of the
best in the country in that not only the theory of music is taught in
the most approved academic fashion, but practice is also afforded in
choral and instrumental music, and it has established a 'university
extension' division for educating the whole people of the state in
music.
3.    It rents out at low cost such materials, including chorus music and material for
     bands and orchestras.
                                         VII
The introduction of music into the public schools has already been
discussed. It is a great tribute to the soundness of the pedagogic
principles laid down by Mason and Woodbridge, the pioneers in
juvenile musical education, that, despite the many new methods
which have been tried, music in the public school is largely
conducted along the original lines. Singing in chorus with use of
specially prepared and successively graded exercises printed on
charts or written on the blackboard and song books, and, most
important of all, under the leadership of a teacher with winning
personality and knowledge of the childish mind, has been found to
produce the best results. So great proficiency has been achieved in
the training of juvenile choruses for musical festivals that the only
really satisfactory choruses given by a great multitude of persons are
the choruses of children, some of which have exceeded three
thousand voices.
New York perfected its system about 1900. The capstone may be
said to be the public musical lectures and performances given in
connection with the evening lecture courses presented in the public
schools and other public buildings under the general auspices of the
Board of Education and the special supervision of Dr. Henry M.
Leipziger.
Indeed, it is only since the beginning of the century that the country
in general has come to recognize at all adequately the supreme
importance of musical culture to community or civic life. As a result
of this recognition there has been a general movement in the central
and western states, and in encouragement of the study of music to
add the forces of private instruction to public by giving credit in the
schools for musical work done outside of them, which credit many
state universities have in turn accepted by admitting high school
graduates upon their certificates.
                                 VIII
While the American people have shown themselves opposed to the
conduct or subsidization of music by the national government, as
this has been often proposed in plans for a national conservatory, we
have seen, in the case of Wisconsin, that this does not apply to the
state governments, at least in respect to the feature of popular
education in music. Still less does it apply to the conduct of music by
the municipal government. For many years the 'city fathers' of most
American municipalities have provided band concerts in the public
parks during the summer season. The programs of these concerts,
however, until quite recently, were planned with little regard to
education of the people in appreciation of the best music—the
selections being of the so-called 'popular' order, the prevalent
opinion of the directors being that the mass of the American people
did not enjoy music of a high order.
'On the recreation piers the band concerts provided by the Dock
Department have been enjoyed by many thousands. An innovation
there has been to classify the program, and give the concerts
distinctive character on different evenings—an Italian Opera Night,
American Night, Wagner Night, Folk Songs and Dances, German-
Slavonic Night, etc....
                                                        M. M. M.
Welcome to our website – the ideal destination for book lovers and
knowledge seekers. With a mission to inspire endlessly, we offer a
vast collection of books, ranging from classic literary works to
specialized publications, self-development books, and children's
literature. Each book is a new journey of discovery, expanding
knowledge and enriching the soul of the reade
Our website is not just a platform for buying books, but a bridge
connecting readers to the timeless values of culture and wisdom. With
an elegant, user-friendly interface and an intelligent search system,
we are committed to providing a quick and convenient shopping
experience. Additionally, our special promotions and home delivery
services ensure that you save time and fully enjoy the joy of reading.
ebooknice.com